The immuno-modulating actions by inhibition of JNK is a common finding in various models of experimental inflammation e.g. animal models for arthritis, pulmonary inflammation, atherosclerosis and other immune challenging procedures (reviewed by [33], [35]). Here, MAPK8 is linked to arthritic joint disease.